A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/B:BREA.0000004375.17920.0b
Reference31 articles.
1. Diab SG, Elledge RM, Clark GM: Tumour characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550-556, 2000
2. Cole MP, Jones CT, Todd ID: A new estrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer 25: 270-275, 1971
3. Miller WR, Stuart M, Sahmoud Y, Dixon JM: Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer. Br J Cancer 87: 950-955, 2002
4. Masamura S, Adlercreutz H, Harvey H: Aromatase inhibitor development for the treatment of breast cancer. Breast Cancer Treat 33: 19-26, 1994
5. Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, EiermannW, Wolter JM, AzabM, Webster A, Plourde PV: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. J Clin Oncol 14: 2000-2011, 1996
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Progress of Selenium Deficiency in the Pathogenesis of Arthropathies and Selenium Supplement for Their Treatment;Biological Trace Element Research;2021-11-15
2. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus;Drug Design, Development and Therapy;2021-08
3. Is There Still a Role for Endocrine Therapy Alone in HR+/HER2– Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies;Breast Care;2019-04-17
4. Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project;Cancer Chemotherapy and Pharmacology;2018-11-20
5. Management of patients with hormone receptor–positive breast cancer with visceral disease: challenges and treatment options;Cancer Management and Research;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3